Citigroup’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$254K Sell
18,311
-5,697
-24% -$90.8K ﹤0.01% 3893
2025
Q4
$390K Sell
24,008
-7,697
-24% -$126K ﹤0.01% 3697
2025
Q3
$474K Sell
31,705
-34,986
-52% -$426K ﹤0.01% 3608
2025
Q2
$777K Sell
66,691
-24,106
-27% -$219K ﹤0.01% 3338
2025
Q1
$675K Sell
90,797
-8,815
-9% -$67.8K ﹤0.01% 3516
2024
Q4
$597K Sell
99,612
-8,929
-8% -$49.2K ﹤0.01% 3705
2024
Q3
$556K Buy
108,541
+47,535
+78% +$207K ﹤0.01% 3662
2024
Q2
$221K Sell
61,006
-79,916
-57% -$254K ﹤0.01% 3831
2024
Q1
$452K Buy
140,922
+114,571
+435% +$443K ﹤0.01% 3643
2023
Q4
$129K Buy
26,351
+19,504
+285% +$89K ﹤0.01% 4101
2023
Q3
$37.3K Sell
6,847
-37,566
-85% -$248K ﹤0.01% 4225
2023
Q2
$298K Buy
44,413
+34,335
+341% +$255K ﹤0.01% 3684
2023
Q1
$89K Sell
10,078
-2,650
-21% -$23.4K ﹤0.01% 4069
2022
Q4
$97.2K Sell
12,728
-1,429
-10% -$11.1K ﹤0.01% 4035
2022
Q3
$101K Sell
14,157
-11,447
-45% -$108K ﹤0.01% 4087
2022
Q2
$207K Sell
25,604
-2,771
-10% -$24.4K ﹤0.01% 3833
2022
Q1
$394K Buy
28,375
+4,047
+17% +$63.6K ﹤0.01% 3661
2021
Q4
$683K Sell
24,328
-5,848
-19% -$179K ﹤0.01% 3590
2021
Q3
$1.03M Sell
30,176
-5,270
-15% -$191K ﹤0.01% 3066
2021
Q2
$1.45M Buy
35,446
+9,655
+37% +$375K ﹤0.01% 2938
2021
Q1
$1.04M Sell
25,791
-4,086
-14% -$221K ﹤0.01% 2956
2020
Q4
$1.77M Sell
29,877
-1,461
-5% -$75.3K ﹤0.01% 2977
2020
Q3
$1.52M Sell
31,338
-2,254
-7% -$94.7K ﹤0.01% 2908
2020
Q2
$1.63M Sell
33,592
-106,842
-76% -$3.9M ﹤0.01% 3046
2020
Q1
$3.9M Buy
140,434
+13
+0% +$363 0.01% 1883
2019
Q4
$4.2M Buy
140,421
+92,486
+193% +$2.66M 0.01% 2178
2019
Q3
$1.48M Buy
+47,935
New +$1.96M ﹤0.01% 3192

Other funds holding ADPT